IL107185A - History of 52-carboxylic acid, processes for their preparation and pharmaceutical preparations containing them - Google Patents

History of 52-carboxylic acid, processes for their preparation and pharmaceutical preparations containing them

Info

Publication number
IL107185A
IL107185A IL107185A IL10718593A IL107185A IL 107185 A IL107185 A IL 107185A IL 107185 A IL107185 A IL 107185A IL 10718593 A IL10718593 A IL 10718593A IL 107185 A IL107185 A IL 107185A
Authority
IL
Israel
Prior art keywords
secocholesta
carboxylic acid
trihydroxy
tetraene
ester
Prior art date
Application number
IL107185A
Other languages
English (en)
Hebrew (he)
Other versions
IL107185A0 (en
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4234382A external-priority patent/DE4234382A1/de
Priority claimed from DE19934317415 external-priority patent/DE4317415A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL107185A0 publication Critical patent/IL107185A0/xx
Publication of IL107185A publication Critical patent/IL107185A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Virology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
IL107185A 1992-10-06 1993-10-05 History of 52-carboxylic acid, processes for their preparation and pharmaceutical preparations containing them IL107185A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4234382A DE4234382A1 (de) 1992-10-06 1992-10-06 25-Carbonsäure-Derivate in der Vitamin D-Reihe, Verfahren zu ihrer Herstellung, Zwischenprodukte für dieses Verfahren, diese Derivate enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
DE19934317415 DE4317415A1 (de) 1993-05-18 1993-05-18 25-Carbonsäure-Derivate in der Vitamin D-Reihe mit Modifikationen in der 20-Position, Verfahren zu ihrer Herstellung, Zwischenprodukte für diese Verfahren, diese Derivate enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln

Publications (2)

Publication Number Publication Date
IL107185A0 IL107185A0 (en) 1994-01-25
IL107185A true IL107185A (en) 1998-02-22

Family

ID=25919406

Family Applications (1)

Application Number Title Priority Date Filing Date
IL107185A IL107185A (en) 1992-10-06 1993-10-05 History of 52-carboxylic acid, processes for their preparation and pharmaceutical preparations containing them

Country Status (21)

Country Link
US (1) US5583125A (fi)
EP (1) EP0663902B1 (fi)
JP (1) JP3565847B2 (fi)
KR (1) KR100294600B1 (fi)
CN (1) CN1042026C (fi)
AT (1) ATE163923T1 (fi)
AU (1) AU671313B2 (fi)
CA (1) CA2146429C (fi)
CZ (1) CZ284926B6 (fi)
DE (1) DE59308257D1 (fi)
DK (1) DK0663902T3 (fi)
ES (1) ES2117150T3 (fi)
FI (1) FI109996B (fi)
HU (1) HU221588B (fi)
IL (1) IL107185A (fi)
MX (1) MX9306204A (fi)
NO (1) NO309599B1 (fi)
NZ (1) NZ256862A (fi)
PL (1) PL175636B1 (fi)
SK (1) SK280651B6 (fi)
WO (1) WO1994007853A1 (fi)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4220757A1 (de) * 1992-06-24 1994-01-05 Schering Ag Derivate in der Vitamin D-Reihe mit Modifikationen in der 20-Position, Verfahren zu ihrer Herstellung, Zwischenprodukte für dieses Verfahren, diese Derivate enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
AU666563B2 (en) * 1992-08-07 1996-02-15 Wisconsin Alumni Research Foundation Preparation of 19-nor-vitamin D compounds
ATE251133T1 (de) * 1993-07-09 2003-10-15 Theramex Neue strukturelle vitamin d derivate
GB9315253D0 (en) * 1993-07-23 1993-09-08 Res Inst Medicine Chem Chemical compounds
ATE189888T1 (de) * 1995-06-14 2000-03-15 Schering Ag Vitamin d-derivate mit substituenten an c-25, verfahren zu ihrer herstellung, zwischenprodukte und die verwendung zur herstellung von arzneimitteln
DE19549243A1 (de) * 1995-12-21 1997-06-26 Schering Ag Pharmazeutische Präparate enthaltend Clathrate von Cyclodextrinen und nichtnatürliche Vitamin D-Analoga
AU2101997A (en) * 1996-03-08 1997-09-22 Isis Innovation Limited Materials and methods relating to the identification of a polymorphism associated with disease susceptibility
DE69814109T2 (de) 1997-09-08 2004-02-26 F. Hoffmann-La Roche Ag 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analoga
DE19744127B4 (de) * 1997-10-01 2006-10-05 Schering Ag Neue Vitamin D-Derivate mit Cyclopropylringen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung sowie ihre Verwendung zur Herstellung von Arzneimitteln
JP2002508383A (ja) * 1997-12-17 2002-03-19 シエーリング アクチエンゲゼルシャフト 側鎖中にリン原子を有するビタミンｄ誘導体
EP0927721A1 (de) * 1997-12-17 1999-07-07 Schering Aktiengesellschaft Neue Vitamin D-Derivate mit Phosphoratomen in den Seitenketten, Zwischenprodukte bei ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
US6531460B1 (en) 1998-10-23 2003-03-11 Teijin Limited Vitamin D, derivatives and remedies for inflammatory respiratory diseases containing the same
US20030188756A1 (en) * 2002-08-19 2003-10-09 Cantorna Margherita T Treatment of inflammatory bowel disease with vitamin d compounds
EP1233942A2 (en) * 1999-12-02 2002-08-28 The Penn State Research Foundation Treatment of inflammatory bowel disease with vitamin d compounds
US6989377B2 (en) * 1999-12-21 2006-01-24 Wisconsin Alumni Research Foundation Treating vitamin D responsive diseases
US6358939B1 (en) * 1999-12-21 2002-03-19 Northern Lights Pharmaceuticals, Llc Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
DE10156596A1 (de) * 2001-11-13 2003-05-28 Schering Ag Vitamin D-Derivate mit Acyloxygruppen in der Seitenkette, Verfahren zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
EP1342796A3 (en) * 2002-02-22 2004-01-02 Teijin Limited Compound for the treatment of paget's disease of bone
AU2003291810A1 (en) * 2002-11-18 2004-06-15 Teva Pharmaceutical Industries Ltd. A crystallization method for purification of calcipotriene
US7704980B2 (en) * 2003-10-08 2010-04-27 Wisconsin Alumni Research Foundation Treatment of inflammatory bowel disease with 2-methylene-19-nor-vitamin D compounds
US7888339B2 (en) 2008-07-10 2011-02-15 Wisconsin Alumni Research Foundation 2-methylene-20(21)-dehydro-19-nor-vitamin D analogs
WO2010053165A1 (ja) 2008-11-04 2010-05-14 帝人ファーマ株式会社 ビタミンｄ３ラクタム誘導体
CN107019795A (zh) 2009-01-27 2017-08-08 博格有限责任公司 用于减轻与化疗有关的副作用的维生素d3化合物
MX366076B (es) 2009-08-14 2019-06-27 Berg Llc Vitamina d3 y analogos de la misma para tratar alopecia.
NZ714801A (en) 2013-05-29 2021-07-30 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin d
US10314395B2 (en) 2017-02-21 2019-06-11 James E. McGhee, III Pallet spacer system and method of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4022891A (en) * 1974-06-18 1977-05-10 Teijin Limited Novel 1α,24-dihydroxycholecalciferol compositions, novel precursors thereof, and processes for preparing them
EP0227826B1 (en) * 1985-08-02 1989-10-25 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Novel vitamin d analogues
GB8914963D0 (en) * 1989-06-29 1989-08-23 Leo Pharm Prod Ltd Chemical compounds
DE3933034A1 (de) * 1989-10-02 1991-04-11 Schering Ag 24-homo-vitamin-d-derivate, verfahren zu ihrer herstellung
AU664213B2 (en) * 1991-11-07 1995-11-09 Research Institute For Medicine And Chemistry Inc. Vitamin D amide derivatives
DE4141746A1 (de) * 1991-12-13 1993-06-17 Schering Ag 20-methyl-substituierte vitamin d-derivate

Also Published As

Publication number Publication date
FI951614A (fi) 1995-04-05
FI951614A0 (fi) 1995-04-05
CA2146429C (en) 2006-12-05
CN1042026C (zh) 1999-02-10
KR100294600B1 (ko) 2001-09-17
DK0663902T3 (da) 1998-12-21
CA2146429A1 (en) 1994-04-14
SK45895A3 (en) 1995-08-09
ES2117150T3 (es) 1998-08-01
CN1094034A (zh) 1994-10-26
PL175636B1 (pl) 1999-01-29
IL107185A0 (en) 1994-01-25
HU221588B (hu) 2002-11-28
US5583125A (en) 1996-12-10
NO951318D0 (no) 1995-04-05
CZ87395A3 (en) 1995-10-18
EP0663902A1 (de) 1995-07-26
DE59308257D1 (de) 1998-04-16
HUT70562A (en) 1995-10-30
NZ256862A (en) 1996-03-26
AU671313B2 (en) 1996-08-22
KR950703526A (ko) 1995-09-20
MX9306204A (es) 1994-05-31
PL308260A1 (en) 1995-07-24
ATE163923T1 (de) 1998-03-15
CZ284926B6 (cs) 1999-04-14
EP0663902B1 (de) 1998-03-11
JPH08501784A (ja) 1996-02-27
FI109996B (fi) 2002-11-15
JP3565847B2 (ja) 2004-09-15
WO1994007853A1 (de) 1994-04-14
NO309599B1 (no) 2001-02-26
NO951318L (no) 1995-06-02
SK280651B6 (sk) 2000-05-16
HU9501002D0 (en) 1995-06-28
AU5177193A (en) 1994-04-26

Similar Documents

Publication Publication Date Title
US5583125A (en) 25-Carboxylic acid derivatives in the vitamin D series, process for their production, intermediate products for these processes, pharmaceutical preparations containing these derivatives as well as their use for the production of pharmaceutical agents
US5700791A (en) Vitamin D derivatives modified in the 20-position and pharmaceutical compositions thereof
JP3280975B2 (ja) ２０−メチル−置換ビタミンｄ−誘導体
CA2477543C (en) Method of synthesizing 1.alpha.-hydroxy-2-methylene-19-nor-homopregnacalciferol
US6372731B1 (en) Vitamin D derivatives with C-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments
US5532228A (en) Side-chain homologous vitamin D derivatives, process for their production, pharmaceutical preparations containing these derivatives and their use as pharmaceutical agents
JP3589664B2 (ja) ビタミンｄ系列の２２−エン−２５−オキサ−誘導体，該化合物の製造法，該誘導体を含有する薬学的調剤ならびに薬剤としての該調剤の使用
AU629831B2 (en) Side chain unsaturated 1 alpha-hydroxyvitamin d homologs for the treatment of leukemia
FI100598B (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten sivuketjuhomologiste n vitamiini-D-johdannaisten valmistamiseksi

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees